Scientists have found a new variant of a deadly strain of bacterial disease that may help eradicate the disease, which causes high rates of hospitalizations and other hospitalizations.
The new strain, called BdM2, is more resistant to the antibiotic tetracycline, and can be found in the intestines of people who have had a stomach ulcer or who have undergone chemotherapy.
“We have found this strain to be more susceptible to antibiotic resistance, so this is a new way to fight this disease,” said Dr. Andrew Leach, an infectious disease expert at the University of Colorado School of Medicine.
“It’s a good, novel and novel-looking way to kill this disease.”
The BdN2 strain is known as a “superbug” because of its resistance to many of the antibiotics that treat it.
It is a highly resistant version of the bacterium that causes Lyme disease.
The new variant was discovered by a team led by microbiologist Dr. Christopher S. Miller, an assistant professor of medicine at the Harvard School of Public Health and lead author of a study published in the journal PLoS One.
The researchers have shown that BdNM2 is capable of producing proteins that are specific for a specific class of antibiotics, known as glycopeptides, that are found in various tissues of the body.
The scientists then showed that this new version of Bd NM2 can survive the tetracellular environment of the stomach, which is a major site of bacterial growth.
“They are able to survive in a very high concentration of aqueous medium,” Miller said.
“And we have seen that it’s able to do this in a small volume of the intestine, which we haven’t seen before.”
The new version can also be produced in a large volume of a solution that has been incubated in the presence of antibiotics.
In other words, the new strain is resistant to several antibiotics that are used to treat bacteria.
“The researchers are able … to grow this particular strain in a solution, and we can also grow it in the lab,” Miller added.
“So they have been able to demonstrate this resistance in the laboratory.
This resistance is a very important aspect of this.”
Miller said that this is the first time that the scientists have found resistance to antibiotics that were used to fight Lyme disease in the human body.
He added that the new version could be used to develop new antibiotics.
“In terms of a new antibiotic that we can develop, we’ve seen in the past that they work pretty well, and the antibiotics they have to work with are the same ones that we’ve used to cure infections like this in the stomach,” Miller told Al Jazeera.
“And this is an alternative antibiotic that could work for other infections, too, because it’s not a part of our existing drug class.”
The findings were published in PLoS ONE.